Screening phage-host receptor interactions using thermal proteome profiling
Screening phage-host receptor interactions using thermal proteome profiling
批准号:
10661882
负责人:
Justin Michael Hutchison
金额:
$21.19万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-10-01 至 2026-05-31
关键词:
AffinityAntibiotic ResistanceBacteriophagesBehaviorBindingBiologyChemicalsClinicalCommunicable DiseasesCytolysisDataDevelopmentEnvironmentExcisionGeneticGoalsHigh-Throughput Nucleotide SequencingHumanImmunocompromised HostInfectionLung infectionsMolecular TargetMycobacteriophagesMycobacterium abscessusOrganismPathogenicityPatient-Focused OutcomesProteinsProteomePublishingReportingResolutionRibosomal RNARisk AssessmentSamplingSourceSputumTechniquesTestingWorkalternative treatmentantimicrobialbasehigh riskmolecular targeted therapiesnovelnovel therapeuticspathogenreceptorscreeningspatial temporal variationtooltreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long-term goal of this work is to correlate environmental reservoirs of pathogenic NTM, mine reservoirs
for NTM-specific mycobacteriophages from correlated environments, and develop a high-throughput tool to
interrogate mycobacteriophage-NTM interactions. The overall objective of this proposal is to increase the
discovery rate of new NTM molecular targets of mycobacteriophages to advance novel therapeutics,
including phage-based treatments. The focus in this proposal is on Mycobacterium abscessus (MABS). While
MABS is the second most common cause of pulmonary infections in the U.S., MABS infections may have
higher rates of adverse patient outcomes compared to more common NTM pathogens. The hypothesis of
this study is MABS-specific mycobacteriophages sourced from MABS-rich samples can be used to identify
novel, phage-based molecular targets for treatment or removal of MABS. The rationale for this project is that
the development of MABS-specific mycobacteriophage tools will contribute to quantitative MABS risk
assessments and promote alternative treatment strategies for antibiotic-resistant MABS.
To achieve the objectives of this proposal and test our hypothesis, we will correlate MABS-rich
environments based on abundance and genetic similarity to pathogenic MABS strains using high-throughput
sequencing data of environmental, human sputum, and clinically isolated samples. Novel, high throughput
sequencing tools are required to capture spatial and temporal variation in MABS subspecies resolution,
presence, and abundance. We will achieve this by employing multilocus, metabarcoding of 16S rRNA, rpoB,
hsp65, and erm(41). Once environmental MABS reservoirs have been correlated, highly ranked
environments will be mined for MABS-specific bacteriophages. Interactions between these
mycobacteriophages and NTM organisms will be screened to identify novel NTM-molecular targets using
thermal proteome profiling. The corresponding mycobacteriophage proteins and previously published reports
for mycobacteriophage proteins with NTM affinity will be used to quantify binding efficiency and determine
lysis from without potential.
Results from this study can inform immunocompromised patient behavior to avoid high-risk NTM reservoirs
and determine if high-throughput sequencing techniques can be applied for species-level resolution of MABS
in human sputum. The development of a high-throughput phage/host-protein screening platform would
accelerate the identification of phage molecular targets, a potential source for the development of novel NTM
antimicrobials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金